Results 231 to 240 of about 6,546 (245)
Some of the next articles are maybe not open access.
InFo Neurologie & Psychiatrie, 2018 Plecanatide, Nusinersen, and Obeticholic acid
Journal of the American Pharmacists Association, 2017Daniel A. Hussar, Deborah K. Douglas
openaire +3 more sources
Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy
Nature Neuroscience, 2017Nusinersen (Spinraza) is a recently approved drug for treating spinal muscular atrophy. Approval of nusinersen may signal new opportunities for using antisense oligonucleotides as treatments for devastating neurological diseases.
openaire +2 more sources
A CSF marker of nusinersen treatment response
Nature Reviews Neurology, 2022openaire +2 more sources
Intrathecal nusinersen administration: Is anesthesia really needed?
Pediatric Anesthesia, 2021Anna Camporesi +2 more
openaire +3 more sources
Transforaminal lumbar puncture for intrathecal nusinersen administration
Muscle & Nerve, 2018Adam Evans +4 more
openaire +2 more sources
Nusinersen in adults with spinal muscular atrophy: new challenges
The Lancet Neurology, 2020Valeria A. Sansone +2 more
openaire +3 more sources